Abiologics
Pre-clinicalAbiologics is surpassing the limits of biology by leveraging artificial intelligence and chemistry to create Synteins™, a new class of supranatural and programmable biologics that aims to redefine what therapeutics can achieve for patients across a range of disease areas.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5M
About
Abiologics is surpassing the limits of biology by leveraging artificial intelligence and chemistry to create Synteins™, a new class of supranatural and programmable biologics that aims to redefine what therapeutics can achieve for patients across a range of disease areas.
Biologics
Funding History
1Total raised:$5M
Seed$5MJun 15, 2022